Ignite Creation Date:
2024-05-06 @ 2:19 AM
Last Modification Date:
2024-10-26 @ 11:16 AM
Study NCT ID:
NCT02014753
Status:
COMPLETED
Last Update Posted:
2019-03-19
First Post:
2013-12-12
Brief Title:
Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent and Platelet AggregatioN studIeS for TreatMent of Acute Myocardial InfarctionTreatment of ST-elevation Acute Myocardial Infarction
Sponsor:
Iwate Medical University
Organization:
Iwate Medical University
Study Overview
Official Title:
Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent and Platelet AggregatioN studIeS for TreatMent of Acute Myocardial Infarction MECHANISM-AMI
Status:
COMPLETED
Status Verified Date:
2019-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MECHANISM-AMI
Brief Summary:
To treat patients with acute myocardial infarction primary percutaneous coronary intervention PCI will be performed with the use of an everolimus-eluting cobalt- chromium stent everolimus-eluting stent EES Xience Prime Xpedition which is the current standard drug-eluting stent DES Vascular responses at the site of stent placement will be evaluated by optical coherence tomography OCT at 2 weeks or 3 months and at 12 months after stent placement along with observation of changes over time in the target vessel The relationships between OCT findings and the time course of platelet aggregation and between OCT findings and the occurrence of major cardio- cerebrovascular events will also be elucidated
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None